GlycoSeLect Announces Investment & Development Partnership with KBI Biopharma
15th August, 2016. Equity investment in initial funding round, license agreement and development project. Dublin, Ireland & Durham, North Carolina, USA
Read MoreNewsroom
JSR Corporation and KBI Biopharma, Inc. Agree to Acquisition; INCJ and CMIC of Japan also participate
Sunnyvale, CA and Tokyo, Japan – February 26, 2015 – JSR Corporation (JSR), along with Tokyo-based CMIC Holdings Co. Ltd. (CMIC) and Innovation...
KBI Biopharma Acquires Biologics Operations in Colorado
RESEARCH TRIANGLE PARK, NC– KBI Biopharma, Inc. (KBI) has signed an agreement with Merck & Co., Inc. (known as Merck in the United States and Canada)...
KBI Biopharma wins 2015 CMO Leadership Award
KBI Biopharma is honored to have been recognized as a winner of a 2015 CMO Leadership Award by Life Science Leader Magazine! This award was based on...
A Comparison of Multimodal Chromatography Resin | Case Study
Mixed Mode Chromatography & KBI's mAB Purification Platform
How KBI Helps Academic/Research Institutions
Every day, academic and research institutions generate massive amounts of data that increase our knowledge about disease and potential therapies. As...
Never Miss Another Update!
Subscribe to KBI's Newsletter, The Pulse, to stay up-to-date on all the latest news, articles, and events from KBI Biopharma.